Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending September 30, 2022 was $9.64 Million (a -3.77% decrease compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense decreased by -888.06%
- Annual Non-operating Income/Expense for 2021 was $21.8 Million (a -135.3% decrease from previous year)
- Annual Non-operating Income/Expense for 2020 was $-61.8 Million (a 1849.31% increase from previous year)
- Annual Non-operating Income/Expense for 2019 was $-3.17 Million (a -95.53% decrease from previous year)
- Twelve month Non-operating Income/Expense ending September 30, 2022 was $25.4 Million (a -55.61% decrease compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense increased by 16.56% year-over-year
Trailing Non-operating Income/Expense for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $25.4 Million | $57.3 Million | $30 Million | $21.8 Million |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Beam Therapeutics Inc.
Most recent Non-operating Income/Expenseof BEAM including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Beam Therapeutics Inc.
Beam Therapeutics Inc. Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $9.64 | $10.02 | $7.01 | – |
| 2021 | $-1.22 | $41.52 | $-17.28 | $-1.19 | $21.83 |
| 2020 | $-54.67 | $2.87 | $-7.93 | $-2.1 | $-61.83 |
| 2019 | $-1.48 | $-0.98 | $-0.21 | $-0.5 | $-3.17 |
| 2018 | – | – | – | – | $-71.0 |
| 2017 | – | – | – | – | $0.07 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology